Decline depth
-30.6%
From rolling 252-day high of $135.34, 291d ago.
Past the 30% Amber threshold.
-30.6%
from rolling 252-day high of $135.34 set 2025-09-22 · 291d ago
Current
$93.93
Decline depth
-30.6%
Decline σ
2.8σ
TFC
4/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$ABT landed on the list 2026-03-08, down 19.0% from its 52-week high that day — now down -30.6%.
That's 10.0 percentage points deeper than the day it joined. It bottomed 40.7% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-09 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
ABT qualifies for the Amber List on decline depth.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 4/5 Amber threshold.
Decline sigma
2.8σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (1.7% per day).
The structural read
What price action says about ABT.
ABT qualifies for the Amber List on decline depth — down -30.6% from its rolling 252-day high.
Cross-confirmation: also showing 4/5 bearish time frames.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2U (green).
Earnings on file: 2026-04-16. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $86.15
14.7% of range
52W high $139.06
Sector context · Healthcare
132 other Healthcare tickers are on Broken Stocks.
62
Red List
33
Amber
37
Watch
-36.9%
Median decline
Worst in sector: UPB (-77.6%). Least-bad: ENTA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to ABT
Amber List
COLL
Collegium Pharmaceutical, Inc.
Amber List
SDGR
Schrodinger, Inc.
Amber List
GYRE
Gyre Therapeutics, Inc.
Amber ListRecovering
NVO
Novo Nordisk A/S
Amber List
RMD
ResMed Inc.
Amber ListRecovering
PHAT
Phathom Pharmaceuticals, Inc.
Questions about ABT
What people ask.
Why is ABT on Broken Stocks?
ABT qualifies for the Amber List on decline depth. It is down -30.6% from its rolling 252-day high of $135.34, set on 2025-09-22 — 291d ago.
Is ABT a falling knife?
Not by the strict technical definition. ABT is down -30.6% from its 52-week high, but that high was set 291d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ABT is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is ABT a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ABT trading inside its 52-week range?
At $93.93, ABT sits 14.7% of the way from its 52-week low ($86.15) to its 52-week high ($139.06). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ABT been declining?
The current 30.6% decline accrued over 291d, which annualizes to roughly -38.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ABT compare to its sector?
There are 132 other Healthcare tickers on Broken Stocks: 62 Red, 33 Amber, 37 Watch, with 46 showing recovering structural signals. Median sector decline is -36.9% — ABT's decline is shallower than the sector median.
Does ABT's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-16) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.